Securing Innovation and Research from Adversaries Act

Summary of S.4525 — Securing Innovation and Research from Adversaries Act

Purpose and intent

• Establishes a prohibition on federally funded research collaborations with certain foreign entities and individuals connected to those entities.
• Aims to reduce national security and other risks by preventing federally funded research from being conducted with restricted parties.

Key provisions and changes

• Prohibition on federally funded research relationships (Section 2, a–b):

  • No federal funds awarded through a federally funded research award may be used by an individual or entity described in subsection (b) to enter into, support, or carry out any research collaboration with:
  • (1) an entity listed on a United States Government restricted entity list; or
  • (2) an individual associated with such an entity.
  • A “research collaboration” is defined broadly to cover joint research activities, co-authorship, data/sharing exchanges, joint laboratories or centers, personnel exchanges, and any other arrangement considered a collaboration by the relevant agency.

• Definition of relevant terms (Section 2, c–e):

  • Federally funded research award: includes grants, contracts, cooperative agreements, other Federal financial assistance, or other award authority.
  • National Laboratory: as defined by the Energy Policy Act of 2005.
  • United States Government restricted entity list: includes several Commerce, Treasury, State, and other U.S. lists (e.g., Entity List, SDN list, Military End-User List, Denied Persons List, Uyghur Forced Labor Prevention Act list, and related restricted-entity designations, plus other designated lists).
  • Research collaboration: inclusively defined to cover joint projects, co-authored outputs, data/software sharing, joint facilities, personnel exchanges, and any other arrangement deemed a collaboration by the funding agency.
  • National security and other lists: encompasses entities and individuals designated for national security, foreign policy, or human rights concerns, including lists related to China-focused companies, defense and export controls, and forced labor prohibitions.

• Guidance and implementation (Section 2, c):

  • The Director of the Office of Science and Technology Policy (OSTP), in consultation with heads of relevant federal research agencies, would issue government-wide guidance to standardize compliance requirements, definitions, and enforcement mechanisms.

• Waiver authority (Section 2, d):

  • Agency heads may grant case-by-case waivers if:
  • (A) waiver is necessary to advance U.S. national security interests; or
  • (B) the collaboration is essential for a clearly defined scientific, public health, or national security purpose that cannot be achieved otherwise.
  • If a waiver is granted, the granting agency head must report to Congress within 30 days, including:
  • The identity of the subject entity or individual,
  • The justification for the waiver,
  • Any mitigation measures to protect national security, if applicable.

• Additional definitions (Section 2, e):

  • Provides detailed definitions for federally funded research awards, national laboratories, and research collaboration, as well as enumerates the lists considered “United States Government restricted entity lists.”

Who would be affected

• Researchers, institutions, and organizations applying for or receiving federal research funding.
• Individuals or entities that participate in or would participate in federally funded research collaborations with restricted entities or associates.
• Federal research agencies and grant/contracting offices responsible for administering funding and ensuring compliance.
• Institutions with existing or planned collaborations that intersect with restricted lists could face prohibition or must seek waivers where applicable.

Procedural and timeline aspects

• The bill directs OSTP to issue implementing guidance in coordination with relevant agencies to standardize definitions and enforcement.
• Waivers are to be decided by the head of the relevant federal agency and, if granted, require a congressional notification within 30 days detailing the waiver and mitigation measures.
• The act provides a framework that could impact ongoing and future federally funded research projects involving restricted entities.

Notable considerations

• The scope relies on the U.S. Government restricted entity lists maintained by multiple agencies, including Commerce, Treasury, Defense, and other designations (e.g., SDN list, Uyghur Forced Labor Prevention Act lists, and other national security-related lists).
• The bill emphasizes national security and integrity of federally funded research, potentially affecting international collaborations and cross-border scientific exchange.
• The waiver mechanism introduces a narrowly scoped exception where withholding collaboration would negatively impact critical national interests or essential science, with transparency requirements to Congress.

This summary captures the bill’s aims, main provisions, affected parties, and key procedural elements based on the introduced text. If you’d like, I can provide a side-by-side clause map or a plain-language FAQ for researchers and university offices.